Jeffrey Davis
Subscribe to Jeffrey Davis's PostsJeffrey is a skilled healthcare executive with substantial knowledge of regulatory advocacy and healthcare policies. Jeffrey’s work focuses on issues tied to provider payment and reimbursement as well as quality reporting. He also has significant experience with recent regulatory developments such as the implementation of surprise billing rules. Read Jeffrey Davis's full bio.
Breaking Down the New No Surprises Act FAQs Post-TMA III
By Drew Elizabeth McCormick, Jamie Gelfman, Kristen O'Brien, Jeffrey Davis and Abygail Hoey on Mar 25, 2025
Posted In Employee Benefits, Health and Welfare Plans
On January 14, 2025, the US Departments of Labor, Health and Human Services, and the Treasury, along with the Office of Personnel Management, released Part 69 of a series of FAQs aimed at helping stakeholders understand and comply with the federal No Surprises Act. This latest set of FAQs focuses on how health plans and...
Continue Reading
Price Transparency: A Trump Administration Regulatory Priority
By Jeffrey Davis and Leigh Feldman on Mar 13, 2025
Posted In Employee Benefits, Health and Welfare Plans
On February 25, 2025, the Trump administration highlighted one of its priorities in an executive order on price transparency. While the order primarily focuses on enforcing existing price transparency requirements, it also suggests potential changes or expansions, which would necessitate rulemaking. Potential impacts on health plans include the requirement to make detailed pricing information publicly...
Continue Reading
No Surprises Act Implementation Under the Trump Administration
By Jeffrey Davis and Kristen O'Brien on Jan 2, 2025
Posted In Employee Benefits, Health and Welfare Plans
The No Surprises Act, a law that ended the practice of “balance billing” by certain out-of-network providers, was enacted as part of the Consolidated Appropriations Act of 2021 on December 27, 2020. While the law was passed during President Trump’s first term in office, the Biden administration has been fully responsible for its implementation to...
Continue Reading
HHS, Labor, and Treasury Finalize Mental Health Parity Rule
By Katie Waldo, Rachel Stauffer, Erica Stocker, Jeffrey Davis, Leigh Feldman, Julia Grabo and Maddie News on Sep 26, 2024
Posted In Employee Benefits, Health and Welfare Plans, Mental Health Parity and Addiction Equity Act
On September 9, 2024, the US Departments of Health and Human Services , Labor, and the Treasury finalized a rule related to the Mental Health Parity and Addiction Equity Act. This rule introduces significant updates to mental health and substance use disorder benefits, ensuring parity with medical and surgical benefits. Key changes include enhanced protections...
Continue Reading
Regs, Regs and More Regs: The Biden Administration Releases Spring 2024 Unified Agenda
By Jeffrey Davis on Aug 8, 2024
Posted In Employee Benefits, Health and Welfare Plans, Mental Health Parity and Addiction Equity Act
The Biden administration recently released its Spring 2024 Unified Agenda (a few months late), which lists all the regulations that the administration plans to issue by the end of the year and beyond. In this update, Jeffrey Davis previews new regulations that could impact the health and welfare benefits industry related to the No Surprises...
Continue Reading
Telehealth: Regulatory Questions Amid Legislative Uncertainty
By Jeffrey Davis and Rachel Stauffer on Jul 18, 2024
Posted In Digital Health, Health and Welfare Plans
One year on from the end of the COVID-19 public health emergency, the Medicare restrictions on telehealth that Congress waived to allow for and expand the use of telehealth and other forms of virtual care are set to expire. Congress has already acted twice to extend the waivers, most recently in the Consolidated Appropriations Act,...
Continue Reading
Surprise Medical Billing Law ‘Not Working the Way We Want It to Work’
By Jeffrey Davis on May 20, 2024
Posted In Executive Compensation, Health and Welfare Plans
A legislative fix to surprise medical billing is not working the way lawmakers imagined it would work. According to this Politico Pro article, private equity groups are disproportionately benefiting from the No Surprises Act, and the law may inadvertently lead to higher health insurance premiums. Access the article.
Continue Reading
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel Medications
By Jeffrey Davis, Paul Radensky, Parashar Patel and Amy Kelbick on May 15, 2024
Posted In Employee Benefits, Health and Welfare Plans
The Centers for Medicare & Medicaid Services (CMS) announced in March that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication. In Wegovy’s case, the FDA recently approved an additional...
Continue Reading
2024 Chart of Healthcare Regulations
By Kristen O'Brien, Rachel Stauffer, Katie Waldo and Jeffrey Davis on Apr 24, 2024
Posted In Employee Benefits, Health and Welfare Plans
During this election year, McDermottPlus is actively monitoring annual regulations that federal agencies are expected to release, as well as “ad hoc” regulations that will be released at the discretion of federal agencies. This chart displays health-related regulations that may be issued this year, organized by federal agency and date of potential release. Access the...
Continue Reading
Doctors Question Medicare Quality Program as More Face Steeper Penalties
By Jeffrey Davis on Nov 28, 2023
Posted In Employee Benefits, Health and Welfare Plans
A Medicare program designed to incentivize high-quality care via physician bonuses is in doubt as providers say it’s caused more trouble than it’s worth. According to this Axios article, the Merit-Based Incentive Payment System has created a disparity between bonus winners and losers, and this disparity is only expected to grow. Access the article.
Continue Reading
